Baliling, Christina A.
HRN: 26-40-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2024
CEFTRIAXONE 1G (VIAL)
12/21/2024
12/28/2024
IV
2gm
OD
CAPMR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes